Skip to main content
. 2022 Nov 10;128(4):505–518. doi: 10.1038/s41416-022-02048-2

Fig. 1. Overview of diverse tumour-associated components in the blood of cancer patients.

Fig. 1

These tumour-related signals can be profiled with different approaches (e.g., targeted sequencing, WES, WGS, WGBS, among others), which are valuable for early cancer detection and MRD monitoring.